Mode of cytotoxic action of T cell-engaging BiTE antibody MT110
- 20 January 2009
- journal article
- Published by Elsevier BV in Immunobiology
- Vol. 214 (6), 441-453
- https://doi.org/10.1016/j.imbio.2008.11.014
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging AntibodyScience, 2008
- BiTE: A new class of antibodies that recruit T-cellsDrugs of the Future, 2008
- Strictly Target Cell-dependent Activation of T Cells by Bispecific Single-chain Antibody Constructs of the BiTE ClassJournal of Immunotherapy, 2007
- Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor ClearanceImmunity, 2007
- Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II StudyClinical Cancer Research, 2007
- MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumorsMolecular Immunology, 2006
- T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody ConstructPublished by The American Association of Immunologists ,2003
- Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibodyInternational Journal of Cancer, 2002
- Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3Current Biology, 1996
- Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme BNature, 1995